Medikabazaar back in the market for a fundraise three years after scandal

₹450 crore from existing and new investors seeking expansion in the wake of the whistleblower-led governance scandal three years ago. The company claims to have turned EBITDA positive and targeted ₹3,000 crore revenue as of FY27.”/>